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Abstract
Rapid identiﬁcation and antimicrobial susceptibility testing (AST) of the causative agent(s) of bloodstream infections are essential for the
selection of appropriate antimicrobial therapy. To speed up the identiﬁcation and AST of the causative agent, the ﬂuid from blood cul-
ture bottles of a Bactec 9240 instrument (Becton Dickinson) containing Gram-positive cocci was mixed with saponin. After a 15-min
incubation, the bacteria were harvested and transferred to the appropriate panel of a BD Phoenix automated microbiology system
(Becton Dickinson) for identiﬁcation and AST. With this approach (referred to as the direct method), we concordantly/correctly identi-
ﬁed 56 (82%) of 68 monomicrobial cultures using the results obtained with the method currently used in our laboratory (current
method) as comparator. Two (3%) isolates could not be identiﬁed and ten (15%) were misidentiﬁed. Complete agreement, concerning
clinical susceptibility categories and MIC values, between the AST results determined with the direct method and the current method
was found for 32 (55%) of 58 isolates. The E-test indicated that the direct method yielded a correct susceptibility proﬁle for 13 of the
remaining 26 blood culture isolates. Therefore, a concordant/correct susceptibility proﬁle (with all antimicrobial agents tested) was
obtained for 45 (77%) of 58 cultures. The overall error rate amounted to 1.9%, with the majority (1.3%) of errors being minor. Impor-
tantly, the results obtained with the direct method were available 12–24 h earlier than those obtained with the current method.
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Introduction
Rapid identiﬁcation and antimicrobial susceptibility testing
(AST) of the causative agent(s) of bloodstream infections are
among the most important tasks of the clinical microbiology
laboratory. This information is essential for clinicians to
select the most appropriate antimicrobial therapy for
patients with bloodstream infections. The current method
for identiﬁcation and AST of bacteria in blood samples
requires an overnight subculture of the bacteria from
which a standard inoculum is prepared for introduction into
an automated system. To shorten the turnaround time
required for identiﬁcation and AST of bacteria, specially
processed ﬂuid from a positive blood culture bottle may be
directly inoculated into an automated system. Indeed,
several studies have compared the direct method with the
current method used in the laboratory [1–9]. The direct
inoculation method yielded acceptable results for Gram-
negative rods, but not for Gram-positive cocci [1–3,5–7].
However, detergents such as saponin by releasing intracellu-
lar bacteria from human blood cells [10], may improve
the recovery of bacteria from positive blood cultures
considerably.
Therefore, the present study aimed to evaluate the accu-
racy of the direct method in which the ﬂuid from positive
blood culture bottles from a Bactec 9240 instrument (Becton
Dickinson) is exposed to saponin for 15 min and then
directly transferred to the BD Phoenix automated microbiol-
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ogy system (Becton Dickinson). For this purpose, we
compared the results of the identiﬁcation and AST of Gram-
positive cocci by this direct method with those obtained by
the method currently used in our laboratory.
Materials and Methods
Blood samples
Blood specimens from patients admitted to the Liver Trans-
plant Intensive Care Unit, the Haematological and Paediatric
Haematological wards, the Neonatology ward and the Burn
Care Centre were inoculated into blood culture bottles
(either Plus Aerobic/F, Plus Anaerobic/F or Peds Plus F; Becton
Dickinson & Co., Milan, Italy). The bottles were collected at
the Unita` Operativa di Microbiologia Universitaria (Azienda
Ospedaliero-Universitaria Pisana, Pisa, Italy) and then trans-
ferred to the Bactec 9240 instrument (software, version
V4.70A) for monitoring bacterial growth by using the stan-
dard growth detection algorithms provided by the system.
From each patient, only the ﬁrst positive blood culture
containing Gram-positive cocci that appeared to be monomi-
crobial in the Gram stain was included in the study. Blood
cultures from 81 patients were investigated. After subcultur-
ing on blood agar plates (Becton Dickinson), 13 (16%) were
found to be polymicrobic and therefore excluded from this
study.
Evaluation of the remaining 68 monomicrobial blood cul-
tures revealed that 42 (62%) contained Staphylococcus epide-
rmidis, eight (12%) contained Staphylococcus hominis, seven
(10%) contained Staphylococcus haemolyticus, three (4%) con-
tained Staphylococcus aureus, one (1%) contained Staphylococ-
cus warneri, four (6%) contained Enterococcus faecium, one
(1%) contained S. agalactiae, one (1%) contained Streptococcus
pyogenes, and one (1%) contained Streptococcus oralis group
mitis. Most (85%) bacteria were coagulase-negative staphylo-
cocci.
Current method for identiﬁcation and AST of bacteria in
blood cultures
Blood culture bottles were placed in the Bactec 9240 instru-
ment for monitoring of the bacterial growth. From the posi-
tive cultures, a small sample was transferred to blood agar
plates, which were incubated overnight at 37C in 5% CO2.
A standardized bacterial suspension (0.65–0.75 McFarland)
was then prepared and the appropriate cards inoculated.
The Vitek 2 system (Vitek 2, software, version R04.03;
advanced Expert system software, version R04.02C; bio-
Me´rieux, Marcy l’E´toile, France) was used as comparator for
identiﬁcation and the AST results, except for Streptococcus
spp. other than S. agalactiae and S. pneumoniae for which the
Phoenix system was used as comparator. The ID GPC cards
were used for the identiﬁcation (ID) of Gram-positive cocci
by the Vitek 2 system. The AST-536 card was used for AST
of staphylococci and the AST-534 card for enterococci and
S. agalactiae. The Phoenix system used ID and AST combina-
tion panels. Bacteria were suspended in Phoenix ID broth
(product no. 246001; Becton Dickinson) and 25 lL of the
suspension were pipetted into the Phoenix AST-S broth
(product no. 246007; Becton Dickinson) previously supple-
mented with one drop of Phoenix AST-S Indicator solution
(product no. 246007; Becton Dickinson). Next, these sus-
pensions were inoculated into the Phoenix ID and AST panel
SMIC/ID (product no. 448858; Becton Dickinson). Once
completely ﬁlled, the panel was logged and loaded into
the Phoenix system instrument for automated reading of the
colorimetric and ﬂuorescence signals every 20 min until
the results for all reactions were obtained. The Phoenix
instrument gives an identiﬁcation result when a species or
species group is identiﬁed at a conﬁdence level of more than
90%.
Detergent
A sterile stock solution of saponin (Sigma-Aldrich Co., St
Louis, MO, USA) at a concentration of 1% was prepared in
Airlife 0.45% sodium chloride (Cardinal Health, Allegiance
Healthcare Corporation, IL, USA) and stored at room tem-
perature until use.
Direct method for identiﬁcation and antimicrobial suscepti-
bility testing of Gram-positive cocci in blood cultures
The direct method is a modiﬁcation of the current method.
In brief, a 7 mL sample from the positive blood culture bot-
tle from the Bactec instrument was incubated with saponin
(0.01% ﬁnal concentration, which was found to be optimal in
our preliminary experiments) for 15 min at room tempera-
ture before transfer to Serum Separator Tubes (BD Vacu-
tainer Systems; Becton Dickinson). Next, bacteria were
sedimented onto the surface of the silicon layer of the vacu-
tainer tube by centrifugation at 2000 g for 10 min. The
supernatant was discarded and the cocci were resuspended
in a Phoenix ID broth and adjusted to the turbidity equiva-
lent of a 0.5 McFarland standard using a PhoenixSpec Nephe-
lometer P/N 440910 (Becton Dickinson). A total of 25 lL of
this suspension was transferred to Phoenix AST broth (prod-
uct no. 246003; Becton Dickinson) supplemented with one
drop of Phoenix AST Indicator solution (Becton Dickinson)
for staphylococci or enterococci, or to Phoenix AST-S broth
supplemented with one drop of Phoenix AST-S Indicator for
streptococci. The suspensions for ID and AST were trans-
CMI Lupetti et al. Phoenix for processing of Gram-positive cocci in blood cultures 987
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 986–991
ferred to the appropriate Phoenix panels. Once completely
ﬁlled, the panels were logged and loaded into the Phoenix
system. We used a BDExpert system (Becton, Dickinson and
Co., Franklin Lakes, NJ, USA), which analyses the antimicro-
bial susceptibility proﬁles for unusual results and ﬂags
potentially erroneous results for veriﬁcation. The results
obtained are reported according to the CLSI guidelines [11].
To determine whether the cards had been inoculated with a
bacterial inoculum of sufﬁcient size, a subculture of serial
dilutions of the suspension for automated ID and AST was
performed on blood agar plates and the number of viable
bacteria determined microbiologically.
Data analysis
Identiﬁcation and susceptibility data obtained by the direct
method were evaluated using the data from the current
method as comparator. The identiﬁcation results were classi-
ﬁed as concordantly identiﬁed, misidentiﬁed (where the bacte-
rium was incorrectly identiﬁed at the genus or species level),
and not identiﬁed. Discrepancies in identiﬁcation of the bacte-
ria between the direct method and the current method were
resolved using the ID32 Staph (bioMe´rieux) or Rapid ID32
Strep systems (bioMe´rieux). In addition, the MIC obtained
using the direct method and the current method were trans-
lated into clinical categories (susceptible, intermediate or
resistant) according to the interpretive criteria of the auto-
mated systems on the basis of microbial identiﬁcation.
Results were recorded as: agreement, very major errors
(false susceptible), major errors (false resistant) and minor
errors (susceptible/resistant vs. intermediately susceptible).
Discrepancies between the results obtained using the direct
and the current method were resolved with the E-test (AB
Biodisk, Solna, Sweden), which was performed in accordance
with the manufacturer’s instructions. CLSI-deﬁned break-
points were used to interpret the results [12].
Quality control
The quality control strains S. aureus subsp. aureus ATCC
12600, Staphylococcus capitis subsp. capitis ATCC 35661,
S. epidermidis ATCC 14990, S. haemolyticus ATCC 29970,
S. hominis ATCC 27844, Staphylococcus lugdunensis ATCC
700328, Staphylococcus simulans ATCC 27851, S. warneri
ATCC 49454, Staphylococcus xylosus ATCC 29971, Entero-
coccus faecalis ATCC 29212 and ATCC 51299, Enterococcus
casseliﬂavus ATCC 700327, and Streptococcus pneumoniae
49619 were included in the identiﬁcation assays weekly;
S. aureus ATCC 29213, ATCC 25923, and ATCC 43300
were included for detection of oxacillin (methicillin)
resistance.
Results
Identiﬁcation of Gram-positive cocci in blood samples by
the direct method and the current method
Comparison of the results obtained with the two methods
revealed concordant identiﬁcation of 53 (78%) of the 68
Gram-positive cocci (Table 1). Sixty-ﬁve (96%) of the 68
isolates were correctly identiﬁed using the current method.
The other three (4%) isolates were correctly identiﬁed by
the direct method. Therefore, 56 (82%) of the 68 isolates
were correctly identiﬁed using the direct method. Two
(3%) isolates (S. pyogenes and S. oralis group mitis) were not
identiﬁed and ten (15%) were misidentiﬁed using the direct
method as compared to the current method. All misidenti-
ﬁed isolates belong to the genus Staphylococcus: one
S. aureus was incorrectly identiﬁed as Pediococcus pentosac-
eus; three of the six S. epidermidis isolates were identiﬁed
as S. hominis, and the other as Staphylococcus saprophyticus,
S. simulans and Staphylococcus caprae; two of the
three S. hominis were identiﬁed as S. epidermidis and the
TABLE 1. Identiﬁcation of Gram-
positive bacterial isolates from 68








Staphylococcus epidermidis 36 6 42
Staphylococcus hominis 5 3 8
Staphylococcus haemolyticus 7 7
Staphylococcus aureus 2 1 3
Staphylococcus warneri 1 1
Enterococcus faecium 4 4
Streptococcus agalactiae 1 1
Streptococcus pyogenes 1 1
Streptococcus oralis group mitis 1 1
Total 56 2 10 68
aUsing the results obtained with the current method as comparator. In the case of discrepancies between the results
obtained with the direct and the current method, bacterial identiﬁcation was made using the ID32 Staph or Rapid
ID32 Strep tests.
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other as S. haemolyticus. In the case of only one S. aureus,
the bacterial load used to ﬁll the Phoenix panel was too
low (104 CFU/mL). Two S. epidermidis isolates, correctly
identiﬁed using the direct method, were misidentiﬁed using
the current method as S. hominis and S. haemolyticus, and
one S. hominis was misidentiﬁed as S. epidermidis.
Antimicrobial susceptibility testing of Gram-positive cocci
in blood cultures by the direct method
AST failed for ﬁve strains of S. epidermidis, two of S. hominis,
one of S. aureus, one of Streptococcus agalactiae and one of
E. faecium for technical reasons of secondary importance,
such as the presence of air bubbles or impurities, clotting in
the wells and the use of an inadequate panel. Therefore, the
results of the AST were available for 48 correctly identiﬁed
isolates, for two isolates correctly identiﬁed only by the
direct method, and for six misidentiﬁed and two unidentiﬁed
isolates. The AST results for the two unidentiﬁed isolates
(S. pyogenes and S. oralis group mitis) showed corresponding
MIC values. AST was performed with 14 antimicrobial agents
with the AST 536 combination panel and with 12 antimicro-
bial agents with the AST 534 combination panel, resulting in
a total of 778 isolate-antimicrobial agent combinations. The
AST results for 56 isolates obtained with the direct method
and the total percentage error as well as the percent error
for each antimicrobial agent are shown in Table 2. The over-
all error rate was 1.9%, including 0.2% very major errors,
0.4% major errors and 1.3% minor errors. The two very
major errors were observed for erythromycin and ciproﬂox-
acin; the major errors for trimethoprim/sulfamethoxazole in
two cases and clindamycin in one case; and the minor errors
mainly for ﬂuoroquinolones, erythromycin, teicoplanin and
linezolid. The categorical agreement for each antimicrobial
agent was greater than 96%. Only ﬂuoroquinolones and
erythromycin showed a categorical agreement of approxi-
mately 95%. Among the antimicrobial agents analysed, the
penicillins, the streptogramin quinupristin/dalfopristin, the
aminoglycoside gentamicin and the glycopeptide vancomycin
showed complete categorical agreement for all isolates.
Furthermore, complete agreement of clinical susceptibility
categories (or MIC values in the case of the unidentiﬁed iso-
lates) was found for 32 (55%) isolates. Using the E-test as
comparator, AST yielded correct results when the direct
but not the current method was used for 11 (19%) correctly
identiﬁed isolates, for one (2%) isolate correctly identiﬁed
only with the direct method (an S. epidermidis isolate mis-
identiﬁed as S. hominis with the current method), and for
one (2%) misidentiﬁed isolate (S. saprophyticus instead of
S. epidermidis). Together, the AST results for 13 (22%) iso-
lates were correct for all antimicrobial agents. Therefore,
using the direct method, concordant/correct AST results
were obtained for 45 (77%) of the 58 isolates for all antimi-
crobial agents.
Discussion
The main conclusion of the present study is that direct
inoculation of saponin-treated samples from a positive
blood culture bottle into the Phoenix system resulted in
the rapid identiﬁcation and AST of Gram-positive cocci.
The detergent most likely lyses the nonmicrobial cells in
blood, thereby releasing the intracellular bacteria. In agree-
ment with this view, we found similar results using other
detergents, including triton and Tween-20 (A. Lupetti,
unpublished observations). Our conclusion is based on
several ﬁndings. First, concordant identiﬁcation of 78% of
the monomicrobial Gram-positive cocci by the direct
method and the current method was noted. Interestingly,
4% of isolates erroneously identiﬁed by the current
method were correctly identiﬁed by the direct method, as
conﬁrmed with the ID32 Staph test. Together, 82% of the
Gram-positive cocci were correctly identiﬁed by the direct
method. Two isolates (3%), one of S. pyogenes and one of
S. oralis group mitis, could not be identiﬁed by the direct
method and ten staphylococci (15%) were misidentiﬁed:
TABLE 2. Antimicrobial susceptibility proﬁles of Gram-posi-




















Ampicillin 56 (100%) 56
Oxacillin 53 (100%) 53
Teicoplanin 2 (4%) 54 (96%) 56
Vancomycin 56 (100%) 56
Clindamycin 1 (2%) 55 (98%) 56
Erythromycin 1 (2%) 2 (4%) 53 (94%) 56




Gentamicin 56 (100%) 56
Levoﬂoxacin 3 (5%) 53 (95%) 56
Ciproﬂoxacin 1 (2%) 2 (4%) 53 (94%) 56
Trimethoprim/
sulfamethoxazole
2 (4%) 54 (96%) 56
Total (%) 2 (0.2%) 3 (0.4%) 10 (1.3%) 763 (98.1%) 778
aUsing the antimicrobial susceptibility testing (AST) results obtained with the
current method in our laboratory as comparator. In the case of discrepancies
between the results obtained with the direct method and the current method,
the AST results were veriﬁed using the E-test. Data are n (%) of bacterial iso-
lates for which the AST results were concordant/correct or erroneous using
the direct method.
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one (2%) at the genus level and nine (13%) at the species
level. Second, the AST results were concordant/correct for
77% of the isolates by the direct method and the overall
error rate of the direct method amounted to 1.9%. The
lowest categorical agreement (approximately 95%) was
found for erythromycin and ﬂuoroquinolones (levoﬂoxacin
and ciproﬂoxacin), whereas there was a categorical agree-
ment >95% for all other antimicrobial agents. Very major
errors were observed only for erythromycin and ciproﬂox-
acin, and major errors for clindamycin and trimethoprim/
sulfamethoxazole. Interestingly, virtually no errors were
observed for vancomycin, teicoplanin and linezolid, the
most frequently used antibiotics to treat systemic infections
caused by staphylococci and enterococci. Third, the results
obtained with the direct method were available at least
12 h earlier than the results obtained with the current
method. Moreover, the recently described increased isola-
tion rate of coagulase-negative staphylococci using the
Phoenix system in the low inoculum mode could further
improve the direct method [13]. Thus, the direct inocula-
tion method combined with the Phoenix system meets the
criteria of the Food and Drug Administration for identiﬁca-
tion and AST of bacteria in routine clinical microbiology
[14].
What are the possible drawbacks of this direct method?
The two main sources of errors regarding identiﬁcation and
AST of Gram-positive cocci by direct methods are mixed
cultures and a too small inoculum size. In the present study,
Gram staining was used to select monomicrobial cultures.
However, other studies reported that 6–10% of the speci-
mens that appeared to be monomicrobial after Gram staining
were later found to be polymicrobial after subculture
[3,8,9,15,16]. Indeed, in the present study, 16% of the speci-
mens appearing to be monomicrobial yielded more than one
isolate, indicating that the results obtained with the direct
method should be considered preliminary until the inoculum
has been conﬁrmed to be monomicrobial by subculture. Of
note, this does not delay the report of the results as the
specimen can be analysed on subcultures inoculated the pre-
vious day.
With respect to the second possible limitation of our
study, only one of the 68 saponin-treated blood samples
contained an insufﬁcient number of bacteria for identiﬁcation
and AST. Because the results obtained with the direct
method are available much earlier than with the current
method, appropriate antimicrobial therapy can be started
earlier, thus reducing health care costs, morbidity and mor-
tality [17]. In addition, adequate antimicrobial therapy will
also reduce the emergence of antimicrobial-resistant strains.
Expecting an important advancement in patient care [18], the
results obtained with the direct method for identiﬁcation
and AST of Gram-positive cocci in monomicrobial blood-
stream infections should be veriﬁed in a larger (and indepen-
dent) study, also including a set of Gram-positive bacteria
that are difﬁcult to identify or that have unusual antimicro-
biol susceptibility proﬁles.
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